Low Female Sexual Desire Clinical Trial
Official title:
Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties, Phase II
The purpose of this study is to pilot test and determine the efficacy of a psychoeducational
intervention (PED) we recently piloted in a group format for women with acquired sexual
arousal disorder (FSAD).
HYPOTHESES:
1. - Compared to baseline measures, the PED will result in significant improvement in
self-report measures of: (a) subjective sexual arousal; (b) perception of genital
arousal/genital sensitivity; (c) orgasmic experience; (d) sexual desire; (e) sexual
distress; (f) relationship satisfaction; (g) depressive symptoms; and (h) quality of
life.
2. - It is unknown what effect the PED will have on actual physiological sexual arousal.
3. - The group format will be a feasible and cost-effective method of delivering
empirically supported treatment to women with sexual arousal difficulties and will
contribute towards meeting the needs for sexual health care for women on the clinic
wait-list at the BC Centre for Sexual Medicine.
Sexual arousal difficulties are common among women, affecting approximately 22% of women
between the ages of 18 and 59 (Laumann, Paik & Rosen, 1999). Although there are
evidence-based psychological treatments available for women with orgasmic and pain
disorders, there are currently no empirically-supported treatments for women with acquired
Sexual Arousal Disorder (FSAD). Moreover, there have been numerous attempts to find evidence
for a pharmacological agent effective at treating women's sexual arousal complaints;
however, to date these studies have been inconclusive. Given the significant role that
sexual health plays in quality of life, the fact that effective psychological treatments for
women's sexual dysfunction are not widely available, and the fact that wait-lists to see
health care professionals with expertise in the area of sexual dysfunction are often
unwieldy, there is a need to establish brief, evidence-based approaches to treat women's
acquired FSAD. Psychological therapy in a group format is a standard practice at the BC
Centre for Sexual Medicine. However, in this study we would like to collect information from
participants that would help us in determining the specific efficacy of the PED as well as
identifying demographic or participant variables that might predict a positive response to
the PED. Because we are using this information to determine the treatment's efficacy and
because we will use this information as the basis for a publication, we deem this to be a
research trial in which ethics review is necessary.
OBJECTIVES: We have recently developed and tested a new psychoeducational treatment (PED)
for the treatment of FSAD due to early-stage gynecologic cancer treatment, and for healthy
women with FSAD. Our data show this PED to significantly improve self-reported sexual
desire, arousal, mood, relationship distress, and quality of life. We are currently testing
the efficacy of this PED in a larger sample of cancer survivors with FSAD. The goal for this
study is to determine the efficacy of the group PED for currently seeking treatment at the
BC Centre for Sexual Medicine for FSAD. By using a waitlist control group, we can determine
if any improvement in sexual function is due to treatment or the passage of time.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01690897 -
Randomized Comparison of Mindfulness Versus Group Support for Treatment of Low Sexual Desire in Women
|
N/A |